NEWS
Related Posts
-
Three Technologies from The University of Osaka Selected for the 3rd KSAC GAP Fund — OUVC to Support Commercialization of a Sulfur Polymer, Heart Failure Drug, and Osteoporosis Treatment Device
-
Our Investment Director, Yuki Taga, Spoke at an Investor Session at SusHi Tech Tokyo 2026
-
J-Pharma Co., Ltd. Listed on the Tokyo Stock Exchange Growth Market
